Virtu Financial LLC Aeglea Bio Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.29 - $0.61 $5,595 - $11,769	19,295 New	19,295 $6,000
Q2 2022 Aug 09, 2022	BUY	$0.5 - $2.66 $15,575 - $82,861	31,151 New	31,151 $16,000
Q1 2021 May 19, 2021	SELL	$6.76 - $8.57 $83,438 - $105,779	-12,343 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$7.02 - $9.83 $86,647 - $121,331	12,343 New	12,343 $97,000
Q4 2017 Feb 09, 2018	SELL	$4.0 - $5.98 $51,740 - $77,351	-12,935 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$2.91 - $4.93 $37,640 - $63,769	12,935	12,935 $0

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.